Dominik Bettenworth Selected Research

heparin proteoglycan

7/2021

Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominik Bettenworth Research Topics

Disease

15	Inflammation (Inflammations) 01/2022 - 09/2011
13	Crohn Disease (Crohn's Disease) 01/2022 - 03/2014
13	Colitis 07/2021 - 03/2013
10	Ulcerative Colitis 02/2022 - 01/2012
7	Pathologic Constriction (Stenosis) 01/2022 - 03/2014
7	Neoplasms (Cancer) 12/2019 - 04/2012
6	Fibrosis (Cirrhosis) 01/2022 - 03/2014
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2020 - 04/2012
3	Infections 12/2017 - 04/2012
3	Autoimmune Diseases (Autoimmune Disease) 12/2017 - 04/2012
2	Cholangiocarcinoma 01/2019 - 01/2019
2	Body Weight (Weight, Body) 11/2018 - 07/2014
2	Carcinogenesis 12/2017 - 04/2017
2	Wounds and Injuries (Trauma) 01/2014 - 09/2011
1	Chronic Disease (Chronic Diseases) 02/2022
1	Disease Progression 02/2022
1	Intestinal Diseases (Diseases, Intestinal) 01/2020
1	Sclerosing Cholangitis 12/2019
1	Colonic Diseases 12/2019
1	Fistula 01/2019
1	Cholangitis 07/2018
1	Hemorrhage 07/2018
1	Pancreatitis 07/2018
1	Pain (Aches) 06/2018
1	Colitis-Associated Neoplasms 12/2017
1	Vascular Diseases (Vascular Disease) 12/2017
1	Adenoma (Adenomas) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Hypersensitivity (Allergy) 08/2014
1	Sclerosis 01/2014
1	Osteoarthritis 01/2014

Drug/Important Bio-Agent (IBA)

8	Dextrans (Dextran)FDA Link 11/2017 - 09/2011
6	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2017 - 09/2011
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2014
3	Janus KinasesIBA 01/2021 - 07/2020
3	tofacitinibIBA 01/2021 - 07/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 09/2011
2	Dextran SulfateIBA 07/2021 - 11/2018
2	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2017
2	AzoxymethaneIBA 04/2017 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 10/2016 - 09/2011
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 01/2016
2	Peroxidase (Myeloperoxidase)IBA 01/2016 - 07/2014
2	SodiumIBA 07/2014 - 03/2013
1	Phosphotransferases (Kinase)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	EnzymesIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Syndecan-1 (Syndecan 1)IBA 07/2021
1	heparin proteoglycanIBA 07/2021
1	AutoantibodiesIBA 11/2020
1	Janus Kinase InhibitorsIBA 07/2020
1	AlarminsIBA 01/2020
1	IntegrinsIBA 12/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	BismuthIBA 01/2019
1	Syndecan-4IBA 11/2018
1	Adalimumab (Humira)FDA Link 06/2018
1	Endothelin A ReceptorIBA 12/2017
1	Endothelin Receptors (Endothelin Receptor)IBA 12/2017
1	Contrast MediaIBA 04/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2017
1	CytokinesIBA 01/2016
1	ChemokinesIBA 01/2016
1	5A peptideIBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	GelatinIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2015
1	GlucocorticoidsIBA 08/2014
1	Niacinamide (Nicotinamide)FDA LinkGeneric 07/2014
1	MTOR InhibitorsIBA 03/2014
1	Tyrosine Kinase InhibitorsIBA 03/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2014
1	TOR Serine-Threonine KinasesIBA 03/2014
1	Interleukin-13IBA 03/2014
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2014
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 01/2014
1	Type 1 Melanocortin ReceptorIBA 01/2014
1	SteroidsIBA 07/2013

Therapy/Procedure

16	Therapeutics 02/2022 - 01/2012
3	Biological Therapy 02/2022 - 01/2017
2	Colectomy 12/2019 - 02/2015
2	Injections 01/2019 - 06/2018
2	Oral Administration 11/2017 - 09/2011
1	Liver Transplantation 01/2019
1	Radiofrequency Ablation 01/2019
1	Length of Stay 07/2018
1	Surgical Instruments (Clip) 07/2018
1	Euthanasia (Mercy Killing) 01/2016
1	Intravenous Injections 01/2016
1	Operative Surgical Procedures 01/2016
1	Catheters 08/2014